Literature DB >> 2348643

Compliance and laboratory data predict relapse rate of Pneumocystis carinii pneumonia during prophylaxis with aerosol pentamidine.

M Opravil1, R Weber, B Ledergerber, R Speich, W Siegenthaler, R Lüthy.   

Abstract

We evaluated 43 AIDS patients on prophylaxis with aerosol pentamidine (60 mg biweekly) after Pneumocystis carinii pneumonia (PCP). The effects of patients' inhalation compliance and of laboratory data during the initial PCP on subsequent PCP relapses were assessed. After a median of 8 months (range, 2-21.5 months) on pentamidine prophylaxis, 13 patients suffered a PCP relapse. Six of them had missed at least one inhalation within the last month before the relapse. Two of these six relapses were fatal. The relapse occurrence was significantly associated with the percentage of missed inhalations. Additional significant associations were found between relapses, low levels of T4 lymphocytes, and elevated serum lactate dehydrogenase during the initial PCP episode (29 patients). Mean levels of T4 lymphocytes were 27/mm3 and 47/mm3 in patients with and without subsequent relapses, mean levels of lactate dehydrogenase were 692 U/L and 605 U/L, respectively. Multivariate Cox regression did not reveal further differences between patients with and without relapses. The increased relapse risk associated with poor inhalation compliance stresses the need for appropriate guidance and motivation of the patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2348643     DOI: 10.1007/bf01648579

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  15 in total

1.  Differences in relative efficiency of nebulisers for pentamidine administration.

Authors:  M J O'Doherty; S Thomas; C Page; D Barlow; C Bradbeer; T O Nunan; N T Bateman
Journal:  Lancet       Date:  1988-12-03       Impact factor: 79.321

2.  Prevention of Pneumocystis carinii pneumonia by inhaled pentamidine.

Authors:  J A Golden; D Chernoff; H Hollander; D Feigal; J E Conte
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

3.  Apical Pneumocystis carinii pneumonia after inhaled pentamidine prophylaxis.

Authors:  D J Conces; J L Kraft; V A Vix; R D Tarver
Journal:  AJR Am J Roentgenol       Date:  1989-06       Impact factor: 3.959

4.  Predictors of the acquired immunodeficiency syndrome developing in a cohort of seropositive homosexual men.

Authors:  B F Polk; R Fox; R Brookmeyer; S Kanchanaraksa; R Kaslow; B Visscher; C Rinaldo; J Phair
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

Review 5.  Current concepts. Treatment of infections associated with human immunodeficiency virus.

Authors:  A E Glatt; K Chirgwin; S H Landesman
Journal:  N Engl J Med       Date:  1988-06-02       Impact factor: 91.245

6.  Bilateral upper lobe Pneumocystis carinii pneumonia in a patient receiving inhaled pentamidine prophylaxis.

Authors:  A G Abd; D M Nierman; J S Ilowite; R N Pierson; A L Bell
Journal:  Chest       Date:  1988-08       Impact factor: 9.410

Review 7.  Pentamidine: a review.

Authors:  M Sands; M A Kron; R B Brown
Journal:  Rev Infect Dis       Date:  1985 Sep-Oct

8.  Elevated lactate dehydrogenase values in patients with Pneumocystis carinii pneumonia.

Authors:  R L Smith; C S Ripps; M L Lewis
Journal:  Chest       Date:  1988-05       Impact factor: 9.410

9.  Serum lactate dehydrogenase levels and Pneumocystis carinii pneumonia. Diagnostic and prognostic significance.

Authors:  M K Zaman; D A White
Journal:  Am Rev Respir Dis       Date:  1988-04

10.  Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus.

Authors: 
Journal:  MMWR Suppl       Date:  1989-06-16
View more
  1 in total

Review 1.  Pneumocystis carinii pneumonia after 40 years.

Authors:  M Nouza
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.